Skip to main content

Advertisement

Table 5 Prevalence per 100 and 95% CIs for the use of stimulants during the year 2000

From: A three-country comparison of psychotropic medication prevalence in youth

  US (n = 127,157) Netherlands (n = 110,944) Germany (n = 356,520)
Age (yr) Male Female Total* Male Female Total* Male Female Total*
0–4 0.76 0.20 0.49 0.08 0.02 0.05 0.02 0.01 0.02
  0.67–0.86 0.15–0.25 0.48–0.49 0.04–0.14 0.00–0.05 0.04–0.06 0.01–0.04 0.00–0.03 0.01–0.02
5–9 10.72 3.68 7.29 2.86 0.63 1.77 1.74 0.40 1.09
  10.19–11.26 3.36–4.03 7.28–7.29 2.58–3.16 0.50–0.78 1.76–1.78 1.62–1.87 0.34–0.46 1.08–1.09
10–14 11.43 3.16 7.40 3.57 0.59 2.12 2.37 0.48 1.45
  10.80–12.07 2.82–3.53 7.39–7.41 3.26–3.9 0.46–0.73 2.11–2.12 2.24–2.50 0.42–0.55 1.45–1.45
15–19 2.75 0.59 1.70 1.17 0.22 0.71 0.42 0.06 0.25
  2.39–3.16 0.44–0.76 1.69–1.71 1.01–1.35 0.15–0.31 0.70–0.71 0.36–0.48 0.04–0.09 0.24–0.25
Total* 6.52 1.94 4.29 1.95 0.37 1.18 1.16 0.24 0.71
  6.52–6.53 1.94–1.95 4.29–4.29 1.95–1.96 0.37–0.37 1.18–1.18 1.16–1.16 0.24–0.24 0.71–0.71
  1. *Totals were adjusted to the child and adolescent population of the US 2000 census by the direct standardization method.